shima rahmani

About shima rahmani

shima rahmani, With an exceptional h-index of 6 and a recent h-index of 6 (since 2020), a distinguished researcher at Tabriz University of Medical Sciences, specializes in the field of autoimmune disease, multiple sclerosis, cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

miR-451a-5p/miR-34a-5p restoration could suppress human breast cancer cell proliferation and migration through Wnt/β-catenin and ERK/P-ERK signaling pathways

The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients

Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trial

The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study

Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study

Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin

hsa-miR-34a-5p potentiates cytarabine-mediated cell cycle arrest in MDA-MB-231 cells: a novel combination therapy

Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial

shima rahmani Information

University

Position

Immunology Research Center Iran

Citations(all)

88

Citations(since 2020)

88

Cited By

1

hIndex(all)

6

hIndex(since 2020)

6

i10Index(all)

3

i10Index(since 2020)

3

Email

University Profile Page

Google Scholar

shima rahmani Skills & Research Interests

autoimmune disease

multiple sclerosis

cancer

Top articles of shima rahmani

miR-451a-5p/miR-34a-5p restoration could suppress human breast cancer cell proliferation and migration through Wnt/β-catenin and ERK/P-ERK signaling pathways

Archives of Razi Institute

2023/10/24

The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients

BMC Research Notes

2023/10/16

Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trial

Clinical Nutrition

2022/5/1

The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study

Biomedicine & Pharmacotherapy

2022/4/1

Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study

Biomedicine & Pharmacotherapy

2022/1/1

Silencing of SiX-4 enhances the chemosensitivity of melanoma cells to Cisplatin

Pathology-Research and Practice

2022/12/1

hsa-miR-34a-5p potentiates cytarabine-mediated cell cycle arrest in MDA-MB-231 cells: a novel combination therapy

Pathology-Research and Practice

2022/8/1

Regulation of NLRP3 inflammasome by zinc supplementation in Behçet's disease patients: A double-blind, randomized placebo-controlled clinical trial

International Immunopharmacology

2022/8/1

Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints

2021/10/1

The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus naïve patients and healthy controls

Gene

2021/2/15

Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease

BMC Research Notes

2020/12

See List of Professors in shima rahmani University(Tabriz University of Medical Sciences)

Co-Authors

academic-engine